These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


424 related items for PubMed ID: 23728790

  • 1. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
    Yasin SA, Ali AM, Tata M, Picker SR, Anderson GW, Latimer-Bowman E, Nicholson SL, Harkness W, Cross JH, Paine SM, Jacques TS.
    Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
    [Abstract] [Full Text] [Related]

  • 2. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.
    Wong M.
    Exp Neurol; 2013 Jun; 244():22-6. PubMed ID: 22015915
    [Abstract] [Full Text] [Related]

  • 3. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
    Scholl T, Mühlebner A, Ricken G, Gruber V, Fabing A, Samueli S, Gröppel G, Dorfer C, Czech T, Hainfellner JA, Prabowo AS, Reinten RJ, Hoogendijk L, Anink JJ, Aronica E, Feucht M.
    Brain Pathol; 2017 Nov; 27(6):770-780. PubMed ID: 27750396
    [Abstract] [Full Text] [Related]

  • 4. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH, Mahadeo T, Bordey A.
    J Neurosci; 2019 Apr 03; 39(14):2762-2773. PubMed ID: 30700531
    [Abstract] [Full Text] [Related]

  • 5. [Expression of autophagy-related proteins in malformations of cortical development].
    Chen S, Piao Y, Fu Y, Li Z, Liu C, Lu D.
    Zhonghua Bing Li Xue Za Zhi; 2015 May 03; 44(5):305-9. PubMed ID: 26178210
    [Abstract] [Full Text] [Related]

  • 6. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
    Grajkowska W, Kotulska K, Matyja E, Larysz-Brysz M, Mandera M, Roszkowski M, Domańska-Pakieła D, Lewik-Kowalik J, Jóźwiak S.
    Folia Neuropathol; 2008 May 03; 46(1):43-8. PubMed ID: 18368626
    [Abstract] [Full Text] [Related]

  • 7. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM, Jensen FE.
    Ann Neurol; 2012 Apr 03; 71(4):539-51. PubMed ID: 22447678
    [Abstract] [Full Text] [Related]

  • 8. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J, Zhang C, Shi X, Wei Y, Liu L, Liu S, Yang H.
    Brain Dev; 2019 Nov 03; 41(10):829-838. PubMed ID: 31495513
    [Abstract] [Full Text] [Related]

  • 9. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Sun FJ, Zhang CQ, Chen X, Wei YJ, Li S, Liu SY, Zang ZL, He JJ, Guo W, Yang H.
    J Neuroinflammation; 2016 Apr 19; 13(1):85. PubMed ID: 27095555
    [Abstract] [Full Text] [Related]

  • 10. [Activation of mTOR in maldeveloped balloon cells and dysmorphic neurons of type II focal cortical dysplasia].
    Lin K, Lin YX, Kang DZ, Ye ZX, Wang XF.
    Zhonghua Bing Li Xue Za Zhi; 2013 May 19; 42(5):311-5. PubMed ID: 24004587
    [Abstract] [Full Text] [Related]

  • 11. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
    van Scheppingen J, Broekaart DW, Scholl T, Zuidberg MR, Anink JJ, Spliet WG, van Rijen PC, Czech T, Hainfellner JA, Feucht M, Mühlebner A, van Vliet EA, Aronica E.
    J Neuroinflammation; 2016 Aug 26; 13(1):202. PubMed ID: 27566410
    [Abstract] [Full Text] [Related]

  • 12. Cell injury and premature neurodegeneration in focal malformations of cortical development.
    Iyer A, Prabowo A, Anink J, Spliet WG, van Rijen PC, Aronica E.
    Brain Pathol; 2014 Jan 26; 24(1):1-17. PubMed ID: 23586324
    [Abstract] [Full Text] [Related]

  • 13. Identifying cellular signalling molecules in developmental disorders of the brain: Evidence from focal cortical dysplasia and tuberous sclerosis.
    Li YF, Scerif F, Picker SR, Stone TJ, Pickles JC, Moulding DA, Avery A, Virasami A, Fairchild AR, Tisdall M, Harkness W, Cross JH, Hargrave D, Guillemot F, Paine SM, Yasin SA, Jacques TS.
    Neuropathol Appl Neurobiol; 2021 Oct 26; 47(6):781-795. PubMed ID: 33797808
    [Abstract] [Full Text] [Related]

  • 14. mTOR pathway activation in focal cortical dysplasia.
    Kumari K, Sharma MC, Kakkar A, Malgulwar PB, Pathak P, Suri V, Sarkar C, Chandra SP, Faruq M.
    Ann Diagn Pathol; 2020 Jun 26; 46():151523. PubMed ID: 32325422
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
    Zimmer TS, Korotkov A, Zwakenberg S, Jansen FE, Zwartkruis FJT, Rensing NR, Wong M, Mühlebner A, van Vliet EA, Aronica E, Mills JD.
    Brain Pathol; 2021 Sep 26; 31(5):e12949. PubMed ID: 33786950
    [Abstract] [Full Text] [Related]

  • 16. Balloon cells in human cortical dysplasia and tuberous sclerosis: isolation of a pathological progenitor-like cell.
    Yasin SA, Latak K, Becherini F, Ganapathi A, Miller K, Campos O, Picker SR, Bier N, Smith M, Thom M, Anderson G, Helen Cross J, Harkness W, Harding B, Jacques TS.
    Acta Neuropathol; 2010 Jul 26; 120(1):85-96. PubMed ID: 20352236
    [Abstract] [Full Text] [Related]

  • 17. Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.
    Patil VV, Guzman M, Carter AN, Rathore G, Yoshor D, Curry D, Wilfong A, Agadi S, Swann JW, Adesina AM, Bhattacharjee MB, Anderson AE.
    Neuropathology; 2016 Apr 26; 36(2):146-56. PubMed ID: 26381727
    [Abstract] [Full Text] [Related]

  • 18. [Expression of PI3K pathway proteins in refractory epilepsy associated with cortical malformation development].
    Ni HC, Sun FH, Piao YS, Ma XL, Lu DH.
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun 26; 41(6):391-5. PubMed ID: 22932407
    [Abstract] [Full Text] [Related]

  • 19. Focal brain malformations: a spectrum of disorders along the mTOR cascade.
    Crino PB.
    Novartis Found Symp; 2007 Jun 26; 288():260-72; discussion 272-81. PubMed ID: 18494264
    [Abstract] [Full Text] [Related]

  • 20. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis.
    Miyata H, Chiang AC, Vinters HV.
    Ann Neurol; 2004 Oct 26; 56(4):510-9. PubMed ID: 15455398
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.